Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cycloph... von Schwartzberg, Lee S, Dr, Modiano, Manuel R, MD, Rapoport, Bernardo L, MD, Chasen, Martin R, MD, Gridelli, Cesare, MD, Urban, Laszlo, MD, Poma, Allen, MD, Arora, Sujata, MSc, Navari, Rudolph M, MD, Schnadig, Ian D, MD

Volltext

Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with... von Rapoport, Bernardo L, Dr, Chasen, Martin R, MD, Gridelli, Cesare, MD, Urban, Laszlo, MD, Modiano, Manuel R, MD, Schnadig, Ian D, MD, Poma, Allen, MD, Arora, Sujata, MSc, Kansra, Vikram, PhD, Schwartzberg, Lee S, MD, Navari, Rudolph M, MD

Volltext

Efficacy of the neurokinin‐1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin‐based chemotherapy von Hesketh, Paul J., Schnadig, Ian D., Schwartzberg, Lee S., Modiano, Manuel R., Jordan, Karin, Arora, Sujata, Powers, Dan, Aapro, Matti

Volltext

Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer von Sweeney, Christopher J, Percent, Ivor J, Babu, Sunil, Cultrera, Jennifer L, Mehlhaff, Bryan A, Goodman, Oscar B, Morris, David S, Schnadig, Ian D, Albany, Costantine, Shore, Neal D, Sieber, Paul R, Guba, Susan C, Zhang, Wei, Wacheck, Volker, Donoho, Gregory P, Szpurka, Anna M, Callies, Sophie, Lin, Boris Kin, Bendell, Johanna C

Volltext

Patient‐physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer von Schnadig, Ian D., Fromme, Erik K., Loprinzi, Charles L., Sloan, Jeff A., Mori, Motomi, Li, Hong, Beer, Tomasz M.

Volltext

APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophospha... von Schnadig, Ian D, Agajanian, Richy, Dakhil, Christopher, Gabrail, Nashat, Vacirca, Jeffrey, Taylor, Charles, Wilks, Sharon, Braun, Eduardo, Mosier, Michael C, Geller, Robert B, Schwartzberg, Lee, Vogelzang, Nicholas

Volltext

APF530 (granisetron injection extended-release) in a three-drug regimen for delayed CINV in highly emetogenic chemotherapy von Schnadig, Ian D, Agajanian, Richy, Dakhil, Christopher, Gabrail, Nashat Y, Smith, Robert E, Taylor, Charles, Wilks, Sharon T, Schwartzberg, Lee S, Cooper, William, Mosier, Michael C, Payne, J Yvette, Klepper, Michael J, Vacirca, Jeffrey L

Volltext

Dosing Patterns, Toxicity, and Outcomes in Patients Treated With First-Line Sunitinib for Advanced Renal Cell Carcinoma in Community-Based Practices von Schnadig, Ian D, Hutson, Thomas E, Chung, Hsingwen, Dhanda, Rahul, Halm, Melissa, Forsyth, Michael, Vogelzang, Nicholas J

Volltext

Light Chain Renal Amyloidosis With Prominent Giant Cells von Troxell, Megan L., MD, PhD, Griffiths, Ryan, MD, Schnadig, Ian, MD, Houghton, Donald C., MD

Volltext

Optimal timing of chemotherapy in androgen independent prostate cancer von Schnadig, Ian D., M.D, Beer, Tomasz M., M.D

Volltext

Gastrointestinal stromal tumors: imatinib and beyond von Schnadig, Ian D, Blanke, Charles D

Volltext

Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study von Siefker-Radtke, Arlene O, Necchi, Andrea, Park, Se Hoon, García-Donas, Jesús, Huddart, Robert A, Burgess, Earle F, Fleming, Mark T, Rezazadeh Kalebasty, Arash, Mellado, Begoña, Varlamov, Sergei, Joshi, Monika, Duran, Ignacio, Tagawa, Scott T, Zakharia, Yousef, Akapame, Sydney, Santiago-Walker, Ademi E, Monga, Manish, O'Hagan, Anne, Loriot, Yohann, Necchi, Andrea, Loriot, Yohann, Park, Se Hoon, Tagawa, Scott, Flechon, Aude, Alexeev, Boris, Varlamov, Sergey, Huddart, Robert, Vano, Yann, Gasparro, Donatello, Hamzaj, Alketa, Kopyltsov, Eugeniy, Gracia Donas, Jesus, Mellado, Begona, Parikh, Omi, Schatteman, Peter, Culine, Stephane, Houédé, Nadine, Zanetta, Sylvie, Facchini, Gaetano, Scagliotti, Giorgio, Schinzari, Giovanni, Lee, Jae Lyun, Shkolnik, Mikhail, Fleming, Mark, Joshi, Monica, O'Donnell, Peter, Stöger, Herbert, Decaestecker, Karel, Dirix, Luc, Machiels, Jean Pascal, Borchiellini, Dephine, Delva, Remy, Rolland, Frederic, Hadaschik, Boris, Retz, Margitta, Rosenbaum, Eli, Basso, Umberto, Mosca, Alessandra, Shin, Dong Bok, Cebotaru, Cristina, Duran, Ignacio, Moreno, Victor, Perez Gracia, Jose Luis, Pinto, Alvaro, Su, Wen-Pin, Wang, Shian-Shiang, Schnadig, Ian, Srinivas, Sandhya, Vogelzang, Nicholas, Loidl, Wolfgang, Meran, Johannes, Gross Goupil, Marine, Joly, Florence, Imkamp, Florian, Krege, Susanne, May, Matthias, Schultze-Seemann, Wolfgang, Strauss, Arne, Zimmermann, Uwe, Keizman, Daniel, Peer, Avivit, Sella, Avishai, Berardi, Rossana, De Giorgi, Ugo, Sternberg, Cora Nanette, Rha, Sun Young, Bulat, Iurie, Izmailov, Adel, Matveev, Vsevolod, Vladimirov, Vladimir, Carles, Joan, Font, Albert, Saez, Maribel, Syndikus, Isabel, Tarver, Kathryn, Appleman, Leonard, Burke, John, Dawson, Nancy, Jain, Sharad, Zakharia, Yousef

Volltext

Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting over multiple cycles of moderately or highly emetogenic chemotherapy von Rapoport, Bernardo, Schwartzberg, Lee, Chasen, Martin, Powers, Dan, Arora, Sujata, Navari, Rudolph, Schnadig, Ian

Volltext

A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck... von Jimeno, Antonio, Bauman, Julie E, Weissman, Charles, Adkins, Douglas, Schnadig, Ian, Beauregard, Patrice, Bowles, Daniel W, Spira, Alexander, Levy, Benjamin, Seetharamu, Nagashree, Hausman, Diana, Walker, Luke, Rudin, Charles M, Shirai, Keisuke

Volltext

Clinical outcomes with bevacizumab-containing and non-bevacizumab–containing regimens in patients with recurrent glioblastoma from US community practices von Chen, Clara, Ravelo, Arliene, Yu, Elaine, Dhanda, Rahul, Schnadig, Ian

Volltext

Safety and Efficacy of Nivolumab in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study von Vogelzang, Nicholas J., Olsen, Mark R., McFarlane, Joshua J., Arrowsmith, Edward, Bauer, Todd M., Jain, Rohit K., Somer, Bradley, Lam, Elaine T., Kochenderfer, Mark D., Molina, Ana, Doshi, Gurjyot, Lingerfelt, Brian, Hauke, Ralph J., Gunuganti, Vijay, Schnadig, Ian, Van Veldhuizen, Peter, Fleming, Mark, Galamaga, Robert, Gupta, Mukul, Hool, Hugo, Hutson, Thomas, Zhang, Joshua, McHenry, M. Brent, Johansen, Jennifer L., Tykodi, Scott S.

Volltext

Treatment of CD30-Positive Systemic Mastocytosis with Brentuximab Vedotin von Borate, Uma, Mehta, Amitkumar, Reddy, Vishnu, Tsai, Michaela, Josephson, Neil, Schnadig, Ian

Volltext

Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy von Chasen, Martin, Urban, Laszlo, Schnadig, Ian, Rapoport, Bernardo, Powers, Dan, Arora, Sujata, Navari, Rudolph, Schwartzberg, Lee, Gridelli, Cesare

Volltext

Sequencing of Cabazitaxel and Abiraterone Acetate After Docetaxel in Metastatic Castration-Resistant Prostate Cancer: Treatment Patterns and Clinical Outcomes in Multicenter Commun... von Sonpavde, Guru, Bhor, Menaka, Hennessy, Daniel, Bhowmik, Debajyoti, Shen, Liji, Nicacio, Leonardo, Rembert, Debra, Yap, Mark, Schnadig, Ian

Volltext

Effect of APF530 on health-related quality of life (QOL) and other chemotherapy-induced nausea and vomiting (CINV) end points: Phase III MAGIC trial von Schnadig, Ian, Braun, Eduardo, Mosier, Michael, Geller, Robert B., Schwartzberg, Lee Steven

Volltext